There is a new viewpoint indicating that anti-CTLA-4 antibodies induce tumor recession by the selective depletion of Tregs in tumors rather than the blocking of B7-CTLA-4 interaction in lymphoid organs (89). Here, CTLA4 is linked to neoplasm.